- Home
- TLS vs PRQR Comparison
TLS vs PRQR Comparison
Compare TLS & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLS
- PRQR
- Stock Information
- Founded
- TLS 1969
- PRQR 2012
- Country
- TLS United States
- PRQR Netherlands
- Employees
- TLS N/A
- PRQR N/A
- Industry
- TLS EDP Services
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- TLS Technology
- PRQR Health Care
- Exchange
- TLS Nasdaq
- PRQR Nasdaq
- Market Cap
- TLS 238.1M
- PRQR 309.5M
- IPO Year
- TLS 2020
- PRQR 2014
- Fundamental
- Price
- TLS $3.41
- PRQR $2.67
- Analyst Decision
- TLS Buy
- PRQR Strong Buy
- Analyst Count
- TLS 5
- PRQR 5
- Target Price
- TLS $4.50
- PRQR $7.60
- AVG Volume (30 Days)
- TLS 347.6K
- PRQR 605.4K
- Earning Date
- TLS 11-12-2024
- PRQR 11-07-2024
- Dividend Yield
- TLS N/A
- PRQR N/A
- EPS Growth
- TLS N/A
- PRQR N/A
- EPS
- TLS N/A
- PRQR N/A
- Revenue
- TLS $122,959,000.00
- PRQR $20,506,357.00
- Revenue This Year
- TLS N/A
- PRQR $235.11
- Revenue Next Year
- TLS $38.31
- PRQR N/A
- P/E Ratio
- TLS N/A
- PRQR N/A
- Revenue Growth
- TLS N/A
- PRQR 306.68
- 52 Week Low
- TLS $1.89
- PRQR $1.61
- 52 Week High
- TLS $5.03
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- TLS 46.50
- PRQR 38.02
- Support Level
- TLS $3.38
- PRQR $2.48
- Resistance Level
- TLS $3.91
- PRQR $2.71
- Average True Range (ATR)
- TLS 0.22
- PRQR 0.29
- MACD
- TLS -0.00
- PRQR -0.08
- Stochastic Oscillator
- TLS 24.24
- PRQR 28.09
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.